STOCK TITAN

Gilead Sciences (GILD) chief exercises RSUs and withholds stock for taxes

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Gilead Sciences, Inc. reported that Johanna Mercier, Chief Communications & Corporate Affairs Officer, exercised restricted stock units on June 10, 2026, converting 2,796 RSUs into the same number of common shares at a stated price of 0.00 per share. Each RSU represents the right to receive one share of common stock and follows a 4-year vesting schedule.

On the same date, 1,341 common shares were disposed of in a tax-withholding transaction at 121.48 per share. Following these transactions, she directly holds 127,234 shares of Gilead common stock and has 27,851 restricted stock units outstanding.

Positive

  • None.

Negative

  • None.

Insights

Compensation-related RSU vesting with routine tax withholding.

Johanna Mercier exercised 2,796 restricted stock units into common shares and had 1,341 shares withheld to satisfy tax obligations. This is a typical pattern for equity compensation rather than an open-market purchase or sale, and the filing shows no discretionary trading.

Following these transactions, she holds 128,575 common shares and 27,851 restricted stock units, indicating a substantial ongoing equity position. The four-year vesting schedule, with 25% vesting after one year and 6.25% quarterly thereafter, ties a portion of her compensation to Gilead’s long-term performance.

Insider Mercier Johanna
Role Chief Comm & Corp Aff Officer
Type Security Shares Price Value
Exercise Restricted Stock Unit 2,796 $0.00 $0.00
Exercise Common Stock 2,796 $0.00 $0.00
Exercise Price or Tax Liability Common Stock 1,341 $121.48 $163K
Holdings After Transaction: Restricted Stock Unit — 27,851 shares (Direct); Common Stock — 127,234 shares (Direct)
Footnotes (2)
  1. F1. Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
  2. F2. The restricted stock units have a 4-year vesting schedule. 25% vest on the first anniversary of the grant date. The balance will vest 6.25% quarterly thereafter until fully vested.
RSUs exercised 2,796 units Restricted Stock Units converted into common stock on 2026-06-10
Tax-withholding shares 1,341 shares Common shares delivered for tax obligations at 121.48 per share
Tax-withholding price 121.48 per share Price used for the F-code tax-withholding disposition
Post-transaction common shares 127,234 shares Direct holdings of Gilead common stock after reported transactions
RSUs outstanding 27,851 units Restricted stock units remaining after the June 10, 2026 exercise
Vesting term 4 years RSUs vest over four years with 25% at first anniversary and 6.25% quarterly
Restricted Stock Unit financial
"Each restricted stock unit represents the contingent right to receive one share"
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
tax-withholding disposition financial
"Payment of exercise price or tax liability by delivering securities"
A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.
Exercise or conversion of derivative security financial
"Transaction code M denotes exercise or conversion of derivative security"
vesting schedule financial
"The restricted stock units have a 4-year vesting schedule"
A vesting schedule is a timeline that determines when someone gains full ownership of certain benefits, such as company stock or retirement contributions. Think of it like earning the right to own a gift gradually over time, rather than receiving it all at once. It matters to investors because it affects when they can fully access or sell these benefits, influencing their financial planning and decision-making.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What did Johanna Mercier report in Gilead (GILD) Form 4 on June 10, 2026?

Johanna Mercier reported exercising 2,796 restricted stock units into common shares and a related tax-withholding disposition of 1,341 shares at 121.48 per share, all involving Gilead Sciences, Inc. common stock.

How many Gilead (GILD) shares does Johanna Mercier hold after this Form 4?

After the reported transactions, Johanna Mercier directly holds 127,234 shares of Gilead common stock. She also has 27,851 restricted stock units outstanding, which may convert into additional shares as they vest under their schedule.

How many restricted stock units did Johanna Mercier exercise in GILD’s Form 4?

She exercised 2,796 restricted stock units, each representing the right to receive one share of Gilead common stock. These units vested under a 4-year schedule before being converted into shares on June 10, 2026.

What portion of Johanna Mercier’s Gilead (GILD) shares were used for taxes?

In a tax-withholding transaction, 1,341 Gilead common shares were disposed of at 121.48 per share. This transaction is reported with code F, indicating shares delivered to satisfy tax obligations from the RSU vesting.

What is the vesting schedule of Johanna Mercier’s GILD restricted stock units?

Her restricted stock units have a 4-year vesting schedule: 25% vest on the first anniversary of the grant date, and the remaining units vest at 6.25% quarterly thereafter until fully vested, subject to continued service.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Mercier Johanna

(Last)(First)(Middle)
GILEAD SCIENCES, INC.
333 LAKESIDE DRIVE

(Street)
FOSTER CITY CALIFORNIA 94404

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
GILEAD SCIENCES, INC. [ GILD ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Comm & Corp Aff Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/10/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/10/2026M2,796A(1)128,575D
Common Stock06/10/2026F1,341D$121.48127,234D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Unit(1)06/10/2026M2,796 (2) (2)Common Stock2,796(1)27,851D
Explanation of Responses:
1. Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
2. The restricted stock units have a 4-year vesting schedule. 25% vest on the first anniversary of the grant date. The balance will vest 6.25% quarterly thereafter until fully vested.
Remarks:
/s/ Amy Kim by Power of Attorney for Johanna Mercier06/11/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)